Janux Therapeutics, Inc. (JANX) quarterly income statement — complete revenue, gross profit & net income history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Sales/Revenue | 3.73M | 7.88M | 10M | 0 | 0 | 0 | 439K | 8.9M | 1.25M | 2.46M | 2.52M | 1.06M | 2.05M | 2.85M | 1.81M | 2.37M | 1.59M | 1.62M | 1.16M | 482K |
| Revenue Growth % | - | - | 2177.9% | -100% | -100% | -100% | -82.56% | 741.72% | -38.87% | -13.5% | 38.83% | -55.31% | 28.89% | 76.05% | 56.43% | 390.66% | 318.16% | - | - | - |
| Cost of Goods Sold | 469K | 8.94M | 501K | 0 | 0 | 0 | 0 | 506K | 532K | 531K | 500K | 14.92M | 15.87M | 0 | 13.74M | 14.09M | 10.18M | 11.17M | 8.41M | 4.74M |
| COGS % of Revenue | 12.56% | 113.45% | 5.01% | - | - | - | - | 5.69% | 42.49% | 21.58% | 19.86% | 1411.92% | 774.66% | - | 757.69% | 595.6% | 640.91% | 691.15% | 725.28% | 982.78% |
| Gross Profit | 3.26M | -1.06M | 9.5M | 0 | 0 | 0 | 439K | 8.39M | 720K | 1.93M | 2.02M | -13.87M | -13.82M | 2.85M | -11.92M | -11.72M | -8.6M | -9.55M | -7.25M | -4.25M |
| Gross Margin % | 87.44% | -13.45% | 94.99% | - | - | - | 100% | 94.31% | 57.51% | 78.42% | 80.14% | -1311.92% | -674.66% | 100% | -657.69% | -495.6% | -540.91% | -591.15% | -625.28% | -882.78% |
| Gross Profit Growth % | - | - | 2063.78% | -100% | -100% | -100% | -78.23% | 160.51% | 105.21% | -32.16% | 116.92% | -18.31% | -60.76% | 129.78% | -64.54% | -175.46% | -456.31% | - | - | - |
| Operating Expenses | 37.48M | 41.34M | 44.75M | 45.12M | 34.9M | 29.02M | 36.28M | 22.21M | 20.88M | 18.07M | 17.83M | 6.88M | 6.46M | 21.11M | 6.1M | 5.54M | 4.95M | 3.94M | 3.66M | 2M |
| OpEx % of Revenue | 1003.94% | 524.63% | 447.5% | - | - | - | 8264.46% | 249.67% | 1667.81% | 734.13% | 708.38% | 650.99% | 315.63% | 742.04% | 336.35% | 234.25% | 311.33% | 243.63% | 315.44% | 414.32% |
| Selling, General & Admin | 11.13M | 10.85M | 10.12M | 10.45M | 9.84M | 8.22M | 17.67M | 7.32M | 6.81M | 6.36M | 6.44M | 6.88M | 6.46M | 5.68M | 6.1M | 5.54M | 4.95M | 3.94M | 3.66M | 2M |
| SG&A % of Revenue | 298.23% | 137.73% | 101.21% | - | - | - | 4024.37% | 82.22% | 544.01% | 258.31% | 255.78% | 650.99% | 315.63% | 199.54% | 336.35% | 234.25% | 311.33% | 243.63% | 315.44% | 414.32% |
| Research & Development | 26.81M | 31.55M | 34.63M | 34.66M | 25.05M | 20.81M | 18.61M | 14.9M | 14.07M | 12.24M | 11.89M | 14.92M | 15.87M | 15.43M | 13.74M | 14.09M | 10.18M | 11.17M | 8.41M | 4.74M |
| R&D % of Revenue | 718.27% | 400.36% | 346.29% | - | - | - | 4240.09% | 167.45% | 1123.8% | 497.4% | 472.47% | 1411.92% | 774.66% | 542.5% | 757.69% | 595.6% | 640.91% | 691.15% | 725.28% | 982.78% |
| Other Operating Expenses | -469K | -1000K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -531K | -500K | -1000K | -1000K | 0 | -1000K | -1000K | -1000K | -1000K | -1000K | -1000K |
| Operating Income | -34.21M | -42.4M | -35.25M | -45.12M | -34.9M | -29.02M | -35.84M | -13.82M | -20.16M | -16.14M | -15.81M | -20.75M | -20.28M | -18.27M | -18.02M | -17.26M | -13.54M | -13.49M | -10.9M | -6.25M |
| Operating Margin % | -916.5% | -538.08% | -352.51% | - | - | - | -8164.46% | -155.36% | -1610.3% | -655.71% | -628.25% | -1962.91% | -990.28% | -642.04% | -994.04% | -729.85% | -852.23% | -834.78% | -940.72% | -1297.1% |
| Operating Income Growth % | 1.96% | -46.1% | 1.65% | -226.42% | -73.09% | -79.85% | -126.66% | 33.38% | 0.59% | 11.66% | 12.26% | -20.2% | -49.76% | -35.4% | -65.29% | -176.09% | -492.91% | -715.11% | - | - |
| EBITDA | -33.74M | -41.88M | -34.75M | -44.58M | -34.38M | -28.51M | -35.33M | -13.32M | -19.63M | -15.61M | -15.31M | -20.28M | -19.83M | -17.86M | -17.77M | -17.15M | -13.46M | -13.43M | -10.88M | -6.24M |
| EBITDA Margin % | -903.94% | -531.5% | -347.5% | - | - | - | -8048.29% | -149.67% | -1567.81% | -634.13% | -608.38% | -1918.35% | -968.16% | -627.87% | -980.31% | -725.29% | -847.14% | -830.82% | -938.4% | -1294.4% |
| EBITDA Growth % | 1.84% | -46.9% | 1.65% | -234.76% | -75.14% | -82.69% | -130.73% | 34.33% | 1% | 12.64% | 13.84% | -18.21% | -47.3% | -33.05% | -63.41% | -174.93% | -491.69% | -715.67% | - | - |
| D&A (Non-Cash Add-back) | 469K | 519K | 501K | 541K | 519K | 512K | 510K | 506K | 532K | 531K | 500K | 471K | 453K | 403K | 249K | 108K | 81K | 64K | 27K | 13K |
| EBIT | -34.21M | -31.95M | -24.31M | -45.12M | -34.9M | -29.02M | -35.84M | -13.82M | -20.16M | -16.14M | -15.81M | -20.75M | -20.28M | -18.27M | -18.02M | -17.26M | -13.54M | -13.49M | -10.9M | -6.25M |
| Net Interest Income | 9.85M | 34.04M | 10.94M | 11.26M | 11.39M | 8.81M | 7.78M | 7.86M | 5.4M | 4.38M | 4.25M | 3.24M | 2.82M | 2.2M | 1.33M | 373K | 132K | 74K | 137K | 46K |
| Interest Income | 9.85M | 34.04M | 10.94M | 11.26M | 11.39M | 8.81M | 7.78M | 7.86M | 5.4M | 4.38M | 4.25M | 3.24M | 2.82M | 2.2M | 1.33M | 373K | 132K | 74K | 137K | 46K |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | 9.85M | 10.46M | 10.94M | 11.26M | 11.39M | 8.81M | 7.78M | 7.86M | 5.4M | 4.38M | 4.25M | 3.24M | 2.82M | 2.2M | 1.33M | 373K | 132K | 74K | 137K | 46K |
| Pretax Income | -24.36M | -31.95M | -24.31M | -33.86M | -23.51M | -20.22M | -28.06M | -5.96M | -14.76M | -11.76M | -11.57M | -17.51M | -17.46M | -16.07M | -16.7M | -16.89M | -13.41M | -13.42M | -10.77M | -6.21M |
| Pretax Margin % | -652.59% | -405.41% | -243.13% | - | - | - | -6391.57% | -66.98% | -1178.91% | -477.77% | -459.59% | -1656.39% | -852.49% | -564.67% | -920.9% | -714.08% | -843.93% | -830.2% | -928.9% | -1287.55% |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -24.36M | -31.95M | -24.31M | -33.86M | -23.51M | -20.22M | -28.06M | -5.96M | -14.76M | -11.76M | -11.57M | -17.51M | -17.46M | -16.07M | -16.7M | -16.89M | -13.41M | -13.42M | -10.77M | -6.21M |
| Net Margin % | -652.59% | -405.41% | -243.13% | - | - | - | -6391.57% | -66.98% | -1178.91% | -477.77% | -459.59% | -1656.39% | -852.49% | -564.67% | -920.9% | -714.08% | -843.93% | -830.2% | -928.9% | -1287.55% |
| Net Income Growth % | -3.63% | -58.02% | 13.35% | -468.18% | -59.27% | -71.93% | -142.56% | 65.96% | 15.46% | 26.81% | 30.71% | -3.67% | -30.19% | -19.75% | -55.08% | -172.12% | -487.13% | -710.63% | - | - |
| Net Income (Continuing) | -24.36M | -31.95M | -24.31M | -33.86M | -23.51M | -20.22M | -28.06M | -5.96M | -14.76M | -11.76M | -11.57M | -17.51M | -17.46M | -16.07M | -16.7M | -16.89M | -13.41M | -13.42M | -10.77M | -6.21M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.39 | -0.51 | -0.39 | -0.55 | -0.38 | -0.36 | -0.51 | -0.11 | -0.30 | -0.25 | -0.25 | -0.42 | -0.42 | -0.39 | -0.34 | -0.40 | -0.32 | -0.33 | -0.26 | -0.62 |
| EPS Growth % | -2.63% | -41.67% | 23.53% | -400% | -26.67% | -44% | -104% | 73.81% | 28.57% | 35.9% | 26.47% | -5% | -31.25% | -18.18% | -30.77% | 35.48% | -459.44% | -153.85% | - | - |
| EPS (Basic) | -0.39 | -0.51 | -0.39 | -0.55 | -0.38 | -0.36 | -0.51 | -0.11 | -0.30 | -0.25 | -0.25 | -0.42 | -0.42 | -0.39 | -0.34 | -0.40 | -0.32 | -0.33 | -0.26 | -0.62 |
| Diluted Shares Outstanding | 62.67M | 61.97M | 62.02M | 61.9M | 61.79M | 56.83M | 54.63M | 54.45M | 49.05M | 46.68M | 45.71M | 41.84M | 41.76M | 41.58M | 41.53M | 41.45M | 41.32M | 41.21M | 41.13M | 10.03M |
| Basic Shares Outstanding | 62.67M | 61.97M | 62.02M | 61.9M | 61.79M | 56.83M | 54.63M | 54.45M | 49.05M | 46.68M | 45.71M | 41.84M | 41.76M | 41.58M | 41.53M | 41.45M | 41.32M | 41.21M | 41.13M | 10.03M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |